Design Therapeutics Announces Second Quarter 2024 Financial Results and Reviews Near-term Milestones for GeneTAC™ Portfolio
Design Therapeutics(DSGN) Newsfilter·2024-08-05 20:00Design Therapeutics(DSGN) Newsfilter·2024-08-05 20:00
R1Design Therapeutics(DSGN) Newsfilter·2024-08-05 20:00